metformin has been researched along with Periphlebitis in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Periphlebitis: Periphlebitis is inflammation of the outer coat of a vein or of tissues surrounding the vein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menon, IS | 1 |
| Dewar, HA | 1 |
| Laursen, B | 1 |
| Gormsen, J | 1 |
2 other studies available for metformin and Periphlebitis
| Article | Year |
|---|---|
Increased blood-urea during phenformin therapy.
Topics: Adult; Female; Fibrinolytic Agents; Humans; Male; Metformin; Middle Aged; Myocardial Infarction; Phe | 1970 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheu | 1969 |